Secondary Hyperparathyroidism (SHPT)
Endocrinology·MeSH: Hyperparathyroidism
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| rayaldee | OPKO HEALTH, INC. (OPK) |
Frequently asked questions
How many drugs are in development for Secondary Hyperparathyroidism (SHPT)?
BioSniper tracks 1 drug in development for Secondary Hyperparathyroidism (SHPT) across 1 company.
How many clinical trials target Secondary Hyperparathyroidism (SHPT)?
There are 1 clinical trial targeting Secondary Hyperparathyroidism (SHPT) tracked by BioSniper.
Deep-dive into Secondary Hyperparathyroidism (SHPT)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis